Adalimumab-adaz

Drug Details

Adalimumab is a medication designed to alleviate pain and swelling associated with various types of arthritis, including rheumatoid, psoriatic, juvenile idiopathic, and ankylosing spondylitis. It is also effective in treating certain skin conditions such as plaque psoriasis and hidradenitis suppurativa. Adalimumab operates by inhibiting a specific protein called tumor necrosis factor (TNF) in the immune system, which is responsible for causing joint inflammation and damage in arthritis and red, scaly skin patches in psoriasis. As part of the TNF blockers drug class, it not only reduces joint swelling but also helps prevent further joint damage, thereby preserving joint function. Additionally, Adalimumab is used for treating specific bowel conditions like Crohn's disease and ulcerative colitis, as well as an eye condition known as uveitis. This information pertains to several Adalimumab products, including adalimumab, adalimumab-aacf, adalimumab-aaty, adalimumab-adaz, adalimumab-adbm, adalimumab-afzb, adalimumab-aqvh, adalimumab-atto, adalimumab-bwwd, adalimumab-fkjp, and adalimumab-ryvk.